
Faculty

Michael R. Clark, MD, MPH, MBA
Associate Professor of Psychiatry and Behavioral HealthJohns Hopkins University School of Medicine
Baltimore, Maryland

Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse PractitionerPonte Vedra Beach, Florida
CME
Accreditation Statements
PHYSICIANS:
The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Successful completion of this CME activity enables the participant to earn up to 3 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
The American Board of Anesthesiology® (ABA) Maintenance of Certification in Anesthesiology™ Program (MOCA)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Maintenance of Certification in Anesthesiology™ program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology.
MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, Safe Means of Administering the Right Therapy - Get SMART has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) and/or an MOC Part II Self-Assessment Activity for the following ABMS Member Boards:
MOC Part II CME Activity
Ophthalmology
Physical Medicine and Rehabilitation
MOC Part II SA
Allergy and Immunology
Colon and Rectal Surgery
Family Medicine
Orthopaedic Surgery
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Please note, MOC credit is reported on a monthly basis.
Credit Designations
PHYSICIANS: The Johns Hopkins University School of Medicine designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, DKBmed, and Johns Hopkins University School of Medicine. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 3.0 contact hour(s) (0.30 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number – JA4008162-9999-19-708-H04-P)
Type of Activity: Knowledge
Upon successfully completing the post-test with a score of 75% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Continuing Dental Education
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between Postgraduate Institute for Medicine and DKBmed.
Postgraduate Institute for Medicine is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of the credit hours by boards of dentistry.
Concerns or complaints about a CE Provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at www.ada.org/cerp.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours. (If applicable for APRNs). Designated for 1.0 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.
PIM Disclosure Information:
The PIM planners and managers have nothing to disclose.
Release Date: 4/12/19
Expiration Date: 3/31/20
Each module is estimated to take 60 minutes to complete.
Learning Objectives:
After completing this activity, the participant will demonstrate the ability to:
- Evaluate and initiate pain management therapy.
- Identify patients with opioid use disorder.
- Perform effective counseling with patients and caregivers about the safe opioid analgesics, including proper storage and disposal.
- Explain how to modify doses and discontinue use of opioid analgesics.
COURSE DIRECTORS
Michael R. Clark, MD, MPH, MBA
Associate Professor of Psychiatry and Behavioral Health
Johns Hopkins University School of Medicine
Baltimore, Maryland
Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse Practitioner
Ponte Vedra Beach, FL
POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to the presentation of the education.
FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:
Planners | Relationship |
---|---|
Michael R. Clark, MD, MPH, MBA | None |
Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP |
Non-CME/CE fees: Salix, Ortho-McNeil Consulting Fees/Advisory Boards: GlaxoSmithKline, Pfizer Royalty fees: Springer Publishing |
No other planners have indicated that they have any financial interest or relationships with a commercial entity.
Note: Grants to investigators at The Johns University are negotiated and administrated by the institution which receives the grants, typically through the office of Research Administration. Individual investigators who participate in the sponsored projects are not directly compensated by the sponsor, but may receive other support from the institution to support their effort on the project(s).
Target Audience
The target audience to complete this program includes any health professionals whom will or have prescribed opioid analgesics in the past 12 months. There are no prerequisites.
Off-label Product Discussion
There will be no discussions of off-label or unapproved uses of drugs or products.
Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Statement of Need
Through a review of the current literature, detailed conversations with expert educators, and a survey of clinicians past program participants, the following core gaps have been identified:
- Prescribers lack adequate education about pain and pain management.
- Proposed learners lack confidence in treating pain and recognizing addictive behavior.
- Clinicians frequently overlook critical components of safe and effective opioid prescribing.
This educational activity is supported by an independent educational grant from Opioid Analgesic REMS Program Companies.
HIPAA STATEMENT
CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS
I certify that I am participating in Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is participating for training, education and/or observation purposes only."
For CME Questions, please contact the CME Office
(410) 955-2959 or e-mail cmenet@jhmi.edu.
For CME Certificates, please call (410) 502-9636.
Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195
Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)